| Project/Area Number |
22659193
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Nagoya University |
|---|
Principal Investigator |
KOJIMA Seiji 名古屋大学, 大学院・医学系研究科, 教授 (20313992)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKAHASHI Yoshiyuki 名古屋大学, 大学院・医学系研究科, 準教授 (40432273)
MURAMATSU Hideki 名古屋大学, 医学部附属病院, 助教 (00572570)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | 内科系臨床医学・小児科学 / 再生不良性貧血 / エピジェネティクス / 骨髄異形成症候群 / パイロシークエンス / エピジエネティクス / 骨髄異形性症候群 / パイロシークエンス法 |
|---|
| Research Abstract |
The differential diagnosis between aplastic anemia(AA) and hypoplastic myelodysplastic syndrome(MDS), especially, refractory cytopenia of childhood(RCC) is still difficult. Six of 9 RCC specimens showed the TP53 gene mutation in TP53 positive stained cells cut by lazer microdissection system, however, there is no TP53 mutation in AA specimens. Furthermore, 2 of 5 RCC specimens showed the highly methylated status in the promotor region of p16 gene, but not in AA specimens. Higher expression of Evi-1, GATA-2 and AML1/RUNX1 were found than those at AA/MDS phase. We also found AML1/RUNX1 and N-RAS mutations occurred in this process.
|
